Stanford Medicine
See the following -
Apple Announces Advancements to ResearchKit
Apple today announced advancements to the open source ResearchKit framework that bring genetic data and a series of medical tests typically conducted in an exam room to iPhone apps. Medical researchers are adopting these new features to design targeted studies for diseases and conditions that affect billions of people around the world and to gather more specific types of data from participants. “The response to ResearchKit has been fantastic. Virtually overnight, many ResearchKit studies became the largest in history and researchers are gaining insights and making discoveries that weren’t possible before,” said Jeff Williams, Apple’s chief operating officer...
- Login to post comments
Parker Foundation Invests $250 Million in Open and Collaborative Cancer Research to Accelerate Innovation
The Parker Foundation today announced a $250 million grant to launch the Parker Institute for Cancer Immunotherapy, a collaboration between many of the country's best scientists, clinicians and industry partners to lead an unprecedented cancer immunotherapy research effort. The gift is the largest single contribution ever made to the field of immunotherapy. The Parker Institute's goal is to accelerate the development of breakthrough immune therapies capable of turning cancer into a curable disease by ensuring the coordination and collaboration of the field's top researchers and quickly translating their findings into patient treatments.
- Login to post comments
Stanford Medicine Launches Health Care Trends Report
Stanford Medicine today published its inaugural Health Trends Report, a comprehensive review and analysis of existing health care research and open-source data, combined with insights from Stanford faculty and external health care experts, on the current and emerging trends facing the health care sector. The report, which will be published annually, found the promise and challenge of big data to be the most important forces driving change and improvements across health care...
- Login to post comments
Stanford’s John Ioannidis On “Underperforming Big Ideas”
In a thought-provoking JAMA commentary out today, Stanford’s John Ioannidis, MD, DSc, and two colleagues call for biomedical researchers — and funding institutions — to “sunset underperforming initiatives.” Nothing controversial there, until you go on to read that some of those initiatives are in the popular fields of gene therapy, stem cell therapy or precision medicine. And, they write, perhaps some less-successful projects have been pursued simply because they fall within a top research field.
- Login to post comments